Cleared Traditional

K791277 - MODEL 6500 EXTRACTION IRRIGATION SYS (FDA 510(k) Clearance)

Class I Obstetrics & Gynecology device.

K791277 · Cavitron Corp. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1979
Decision
43d
Days
Class 1
Risk

K791277 is an FDA 510(k) clearance for the MODEL 6500 EXTRACTION IRRIGATION SYS. Classified as Dilator, Cervical, Fixed Size (product code HDQ), Class I - General Controls.

Submitted by Cavitron Corp. (Mchenry, US). The FDA issued a Cleared decision on August 22, 1979 after a review of 43 days - a notably fast clearance cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.4530 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cavitron Corp. devices

Submission Details

510(k) Number K791277 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 10, 1979
Decision Date August 22, 1979
Days to Decision 43 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
117d faster than avg
Panel avg: 160d · This submission: 43d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code HDQ Dilator, Cervical, Fixed Size
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 884.4530
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.